SAN DIEGO, Nov. 17, 2014 /PRNewswire/ -- Volcano Corporation
(Nasdaq: VOLC), a leading company focused on improving patient and
economic outcomes on a global basis by developing and delivering
innovative minimally invasive coronary and peripheral
visualization, physiology diagnostics and therapies, said today it
will be participating in the Canaccord Genuity Medical Technology
& Diagnostics Forum on Thursday,
November 20.
The presentation by John
Dahldorf, chief financial officer, will begin at
3 p.m., Eastern Standard Time
(12 p.m., Pacific Standard Time). The
presentation will be available through the conference website at
http://www.wsw.com/webcast/canaccord16/volc and via the company's
website at www.volcanocorp.com.
About Volcano Corporation
Through its multi-modality platform, Volcano Corporation is the
global leader in intravascular imaging for coronary and peripheral
therapeutic devices. The company's broad range of technologies
makes imaging and therapy simpler, more informative and less
invasive and offers physicians and their patients around the world
with industry-leading tools that aid diagnosis and guide and
provide therapy. Founded in cardiovascular care and expanding into
other specialties, Volcano is focused on improving patient and
economic outcomes. For more information, visit the company's
website at www.volcanocorp.com
SOURCE Volcano Corporation